Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 1999

View Archived Issues

Intranasal morphine achieves plasma levels similar to intramuscular injection

Resolution presents nine papers at Society of Nuclear Medicine meeting

AxyS Pharmaceuticals enters combinatorial chemistry collaboration with Novalon

Immunex renews gene license with Digital Gene Technologies

J&J Medical and Integra LifeSciences announce marketing alliance for Integra Artificial Skin

Study results published for Atridox periodontal therapy

Phase II results reported for Novavax's Estrasorb

FDA clears Cutivate cream for treatment of atopic dermatitis in children

Interferon alfa for treatment of HPV successfully delivered without injection

Transgene initiates phase I trial of malignant melanoma product

Avant achieves milestone in rotavirus vaccine program with SB

Antiallergic agents in the pipeline at Asahi Chemical

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

Pharsight's KADD expected to accelerate clinical drug development at AstraZeneca

Another series of factor Xa inhibitors patented by AxyS

Potent and selective arylpyrrolidine 5-HT1A ligands presented by Korean investigators

Insulin glargine: an improved treatment option for insulin-requiring diabetics

Inhaled insulin is comparable to s.c. insulin in terms of efficacy and safety

MENT increases sexual activity and may improve mood in hypogonadal men

Elcometrine implant provides safe and effective contraception in nursing women

Daclizumab may have applications in uveitis therapy

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

AC-6 gene shows positive preclinical results in cardiomyopathy

Tipranavir is active against 90% of HIV strains with high resistance to protease inhibitors

Gliadel successfully completes mutual recognition procedure in 10 E.U. countries

Novel KAT inhibitors for age-related and perinatal cognition disorders

German pharmaceutical giant teams up with national biotech upstart in life science research

Novel beta3-adrenoceptor-selective antidiabetic candidates synthesized at Yamanouchi

Pierre Fabre profiles 5-HT1B/1D agonist at headache meeting in Barcelona

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...